International Stem Cell Corporation is a biotechnology company with a powerful new stem cell technology called parthenogenesis which uses unfertilized eggs, and promises to significantly advance the field of regenerative medicine by addressing the problem of immune-rejection.
ISCO are focused on using these stem cells to treat diseases of the eye, the nervous system and the liver, where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells or tissue.
Parthenogenesis (from the Greek parthenos meaning "virgin" and genesis meaning "birth") utilizes unfertilized human eggs to create parthenogenetic stem cells (hpSC) that can be immune-matched to millions of people. A relatively small number of hpSC lines could provide sufficient immune-matched cells to cover a large percentage of the world’s population.
ISCO’s scientists are focused on using hpSC to treat severe diseases of the eye, the nervous system and the liver where cell therapy has been proven clinically yet is limited by the availability of safe immune-matched human cells.
International Stem Cell Corp. is a fully reporting company, publicly traded on the OTC Market under the symbol “ISCO”, and within the OTC-QB market tier. As such, Business, Operational and Financial information on International Stem Cell Corp. is available to public view.
(Please note the share structure posted is what we have gathered but can change on a daily basis. Contact the Company or Transfer Agent to get the most current information.)
Securities Transfer Corp. 2591 Dallas Parkway - Suite 102 Frisco, TX 75034
News Disclaimer
The following Press Releases have not been investigated by Penny Stocks on Steroids, therefore, we have no idea if the content of this news is based on Fact or Fiction. Although the links for the following press releases may be from familiar and reputable news sources, you should NOT assume that a press wire hosted by a website you are familiar with is accurate just because it is on their site. Penny Stocks on Steroids will not be held responsible for any news release, including and not limited to misleading or non-factual content, or the accuracy of the identity of the given source of the press release.
International Stem Cell Corp. Corporate Headquarters 5950 Priestly Drive Carlsbad, CA 92008
Fax: 760-476-0600 Phone: 760-940-6383
East Coast Office 8425 Progress Drive - Suite Z Frederick, MD 21701
Fax: 301-845-2405 Phone: 877-845-7787
Investor and Media ir@intlstemcell.com
Business Development bd@intlstemcell.com
Human Resources hr@intlstemcell.com
This Alert brought to you by Penny Stocks on Steroids
Contact Us - admin@pennystocksonsteroids.com
Penny Stocks are very volatile and with investing in any security there is always risk.
Always Educate yourself and do your own Due Diligence before investing in ANY Security.
If you are new to trading penny stocks we strongly advise you to spend some time trading virtual money. They say that “You never really become a real trader until you wipe out your portfolio.” We say take that wipeout while not losing your real money.
Here are a few sites where you can easily set up a virtual account:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.